Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated Fascial Traction in Patients With Open Abdomen (VAWCPOM)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05568238 |
Recruitment Status :
Not yet recruiting
First Posted : October 5, 2022
Last Update Posted : October 5, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Open abdomen therapy is used in trauma and non-trauma patients where the abdomen is not possible to close, or the intraabdominal conditions is not suitable for closure. In 2007, a new technique that made use of negative pressure wound therapy and mesh-mediated fascial traction for closure of the open abdomen was described from the Department of Surgery in Malmö, Sweden. With this new technique, fascial closure rates were high but long-term incisional hernia formation was seen in approximately half of the patients alive after five years. To overcome the high incisional hernia incidence, a new technique utilizing a permanent on-lay mesh for traction and reinforcement of the incision at fascial closure was developed.
Hypothesis Lower incisional hernia rates in comparison with literature reported results of other techniques for open abdomen treatment, with similar complication rates.
Aims To evaluate early and late clinical outcome of the novel vacuum-assisted wound closure and permanent on-lay mesh-mediated fascial traction technique.
Design A prospective six-center cohort study in Sweden and Denmark. Study inclusion during a two-year period or longer to include at least 100 patients. Statistical analysis will be done by intention-to-treat and as sub-group per-protocol analysis.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Open Abdomen Temporary Abdominal Closure Incisional Hernia | Procedure: Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated fascial traction (VAWCPOM) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated Fascial Traction (VAWCPOM) in Patients With Open Abdomen - a Prospective Multi-center Cohort Study |
Estimated Study Start Date : | October 2022 |
Estimated Primary Completion Date : | December 2024 |
Estimated Study Completion Date : | December 2027 |
Arm | Intervention/treatment |
---|---|
Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated fascial traction
Incisional hernia incidence for patients treated with Vacuum Assisted Wound Closure and Permanent On-lay Mesh mediated fascial traction
|
Procedure: Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated fascial traction (VAWCPOM)
Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated fascial traction (VAWCPOM) in patients with open abdomen. |
- Incisional hernia at 1 year [ Time Frame: 1 year, year 1 ]Incidence of incisional hernia after open abdomen closure with the technique
- Fascial closure rate [ Time Frame: During hospital stay ]Percentage of patients possible to closed with the technique
- Complications [ Time Frame: Up to 12 weeks ]Complications related to the technique
- Incisional hernia [ Time Frame: Through study completion, 3 years ]Incisional hernia incidence after three years
- EQ5D [ Time Frame: Through study completion, 3 years ]Patient reported outcome of generic quality of life
- HERO [ Time Frame: Through study completion, 3 years ]Patient reported outcome of abdominal wall function and discomfort
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
• All patients ≥18 years old treated with an open abdomen with a midline incision, regardless of indication.
Exclusion Criteria:
- Patient declining participation
- Existing incisional hernia or primary ventral hernia ≥3 cm
- Existing mesh in the abdominal wall, located in the midline and irrespective of mesh size
- Existing ostomy/parastomal hernia located in a position that prevents the VAWCPOM technique to be utilized
- Closure of the abdomen at first dressing change, e. g. without mesh traction
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05568238
Contact: Ulf Pettersson, Ass prof | +46705657446 | ulf.a.petersson@telia.com | |
Contact: Peder Rogmark, MD, PhD | +46 40 333398 | peder.rogmark@skane.se |
Principal Investigator: | Ulf Pettersson, Ass prof | Lund University, Sweden. Department of Surgery Skane university hospital, Sweden |
Responsible Party: | Ulf Petersson, Principal investigator, Skane University Hospital |
ClinicalTrials.gov Identifier: | NCT05568238 |
Other Study ID Numbers: |
131-22 |
First Posted: | October 5, 2022 Key Record Dates |
Last Update Posted: | October 5, 2022 |
Last Verified: | September 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Incisional Hernia Hernia Pathological Conditions, Anatomical Postoperative Complications Pathologic Processes |